NCT05310942

Brief Summary

The study aims to evaluate the accuracy of fluid responsiveness assessment with non-invasive cardiometry compared to ultrasound guided inferior vena cava (IVC) collapsibility for management of critically ill septic patients with hemodynamic instability.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 17, 2021

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 3, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 5, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2023

Completed
Last Updated

April 19, 2022

Status Verified

March 1, 2022

Enrollment Period

17 days

First QC Date

March 27, 2022

Last Update Submit

April 12, 2022

Conditions

Keywords

fluid responsivenesscardiometryIVC collapsibility

Outcome Measures

Primary Outcomes (1)

  • Fluid responsiveness

    The study primary outcome will be the cardiac index determined by the non-invasive cardiometry in correlation with ultrasound guided IVC collapsibility index to determine which is more effective in prediction of fluid responsiveness.

    2 years

Secondary Outcomes (3)

  • total infused fluid from ICU arrival till the goal is achieved

    2 years

  • total dose of vasopressor and inotrope taken during ICU stay period

    2 years

  • time to weaning of vasopressors and inotropes

    2 years

Study Arms (2)

A

The fluid management of patients in this group will be assessed by IVC collapsibility index (IVC CI) calculated by ultrasound through maximum IVC diameter - minimum IVC diameter divided by maximum diameter then multiplied by 100. If it is less than 50% means that the patient is volume non- depleted while if it is more than 50% means the reverse.

B

All patients in this group with sepsis will be evaluated by the electrical cardiometry monitor.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Enrolment of eligible patients will occur within 8 h of meeting the criteria for septic shock. All patients will be randomized using the computer-generated software of randomization and sealed closed envelopes to allocate them to one of two groups (30 patients each). Routine measurements and investigations will be taken at admission to intensive care unit; history, vital signs, routine laboratory investigation.

You may qualify if:

  • ASA class I and II
  • Age 18-65 years old of both genders.
  • Fulfilment criteria of sepsis as defined according to the standard Surviving Sepsis Campaign criteria using the Sequential (sepsis-related) Organ Failure Assessment (SOFA) score (SOFA score ≥ 2 indicated organ dysfunction).
  • Patients within 8 h of meeting the criteria for septic shock.

You may not qualify if:

  • Lack of consent
  • Age below 18 and above 65 years old.
  • acute coronary syndrome
  • major cardiac dysrhythmia,
  • valvular or congenital heart disease
  • Massive bilateral pleural effusion
  • Severe anaemia
  • End-stage kidney disease (ESKD) patients with Creatinine clearance (CrCl) \<50ml/min.
  • Child B and Child C hepatic patients
  • impaired systolic function according to the ejection fraction (EF) (EF \< 40% indicated impaired systolic function)
  • Severe ARDS (acute respiratory distress syndrome).
  • Tense ascites
  • Mechanical ventilation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine

Banhā, 13518, Egypt

Location

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assisstant lecturer at faculty of medicine

Study Record Dates

First Submitted

March 27, 2022

First Posted

April 5, 2022

Study Start

December 17, 2021

Primary Completion

January 3, 2022

Study Completion

January 1, 2023

Last Updated

April 19, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations